Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis
- Resource Type
- Article
- Authors
- Muchtar, Eli; Gertz, Morie A.; LaPlant, Betsy R.; Buadi, Francis K.; Leung, Nelson; O'Brien, Patrick; Bergsagel, P. Leif; Fonder, Amie; Hwa, Yi Lisa; Hobbs, Miriam; Helgeson, Dania K.; Bradt, Erin E.; Gonsalves, Wilson; Lacy, Martha Q.; Kapoor, Prashant; Siddiqui, Mustaqueem; Larsen, Jeremy T.; Warsame, Rahma; Hayman, Suzanne R.; Go, Ronald S.; Dingli, David; Kourelis, Taxiarchis V.; Dispenzieri, Angela; Rajkumar, S. Vincent; Kumar, Shaji K.
- Source
- In Blood Advances 27 September 2022 6(18):5429-5435
- Subject
- Language
- ISSN
- 2473-9529